Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ

Breast Journal

Volumn 18, Issue 2, 2012, Pages 151-156

  Kropcho, Luisa C ^a   Steen, Shawn T ^a   Chung, Alice P ^a   Sim, Myung Shin ^a   Kirsch, Daniel L ^a,b   Giuliano, Armando E ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b Tower Imaging Medical Group   (United States)

Author keywords

ductal carcinoma in situ; MRI; tumor margin

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST BIOPSY; CANCER GRADING; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84858291324     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2011.01204.x     Document Type: Article

References (37)

1. Virnig BA, Tuttle TM, Shamliyan T, Kane RL,. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 2010; 102: 170-8.
2. Schouten van der Velden AP, Boetes C, Bult P, Wobbes T,. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 2006; 192: 172-8. (Pubitemid 44066305)
3. Thomas J, Evans A, Macartney J, et al. Radiological and pathological size estimations of pure ductal carcinoma in situ of the breast, specimen handling and the influence on the success of breast conservation surgery: a review of 2564 cases from the Sloane Project. Br J Cancer 2010; 102: 285-93.
4. Dillon MF, Mc Dermott EW, O'Doherty A, Quinn CM, Hill AD, O'Higgins N,. Factors affecting successful breast conservation for ductal carcinoma in situ. Ann Surg Oncol 2007; 14: 1618-28. (Pubitemid 46790985)
5. Ramanah R, Pivot X, Sautiere JL, Maillet R, Riethmuller D,. Predictors of re-excision for positive or close margins in breast-conservation therapy for pT1 tumors. Am J Surg 2008; 195: 770-4. (Pubitemid 351749454)
6. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356: 1295-303. (Pubitemid 46513295)
7. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351: 427-37.
8. Orel SG, Schnall MD, LiVolsi VA, Troupin RH,. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190: 485-93. (Pubitemid 24044258)
9. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995; 197: 387-95.
10. Gilles R, GuinebretiÃ̈re JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994; 191: 625-31. (Pubitemid 24177876)
11. Soderstrom CE, Harms SE, Copit DS, et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996; 201: 427-32. (Pubitemid 26357638)
12. Santamaria G, Velasco M, Farrús B, Zanõn G, Fernández PL,. Preoperative MRI of pure intraductal breast carcinoma - a valuable adjunct to mammography in assessing cancer extent. Breast 2008; 17: 186-94. (Pubitemid 351467956)
13. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007; 370: 485-92. (Pubitemid 47214635)
14. Fadare O, Clement NF, Ghofrani M,. High and intermediate grade ductal carcinoma in-situ of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close or positive margin in the excision. Diagn Pathol 2009; 4: 26.
15. Allen LR, Lago-Toro CE, Hughes JH, et al. Is there a role for MRI in the preoperative assessment of patients with DCIS? Ann Surg Oncol 2010; 17: 2395-400.
16. Ross RJ, Thompson JS, Kim K, Bailey RA,. Nuclear magnetic resonance imaging and evaluation of human breast tissue: preliminary clinical trials. Radiology 1982; 143: 195-205. (Pubitemid 12142200)
17. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200: 639-49. (Pubitemid 26282258)
18. Schouten van der Velden AP, Schlooz-Vries MS, Boetes C, Wobbes T,. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg 2009; 198: 262-9.
19. Esserman LJ, Kumar AS, Herrera AF, et al. Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol 2006; 24: 603-10.
20. Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM,. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 2003; 10: 381-8. (Pubitemid 40486935)
21. Neubauer H, Li M, Kuehne-Heid R, Schneider A, Kaiser WA,. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 2003; 76: 3-12. (Pubitemid 36236293)
22. Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R,. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience. Breast J 2005; 11: 242-7. (Pubitemid 41026037)
23. Melstrom LG, Melstrom KA, Wang EC, Pilewskie M, Winchester DJ,. Ductal carcinoma In Situ: size and resection volume predict margin status. Am J Clin Oncol 2009; 33: 438-42.
24. Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol 2006; 45: 536-43. (Pubitemid 44167203)
25. EORTC Breast Cancer Cooperative Group; EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006; 24: 3381-7. (Pubitemid 46638893)
26. Dunne C, Burke JP, Morrow M, Kell MR,. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009; 27: 1615-20.
27. Macdonald HR, Silverstein MJ, Lee LA, et al. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast. Am J Surg 2006; 192: 420-2. (Pubitemid 44344210)
28. Meijnen P, Gilhuijs KG, Rutgers EJ,. The effect of margins on the clinical management of ductal carcinoma in situ of the breast. J Surg Oncol 2008; 98: 579-84.
29. Grobmyer SR, Mortellaro VE, Marshall J, et al. Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy? J Am Coll Surg 2008; 206: 1045-50; discussion 1050-2.
30. Hollingsworth AB, Stough RG, O'Dell CA, Brekke CE,. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg 2008; 196: 389-97.
31. Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 2009; 209: 180-7; quiz 294-5.
32. Hwang N, Schiller DE, Crystal P, Maki E, McCready DR,. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol 2009; 16: 3000-9.
33. Pengel KE, Loo CE, Teertstra HJ, et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat 2009; 116: 161-9.
34. Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 2010; 375: 563-71.
35. Peters NH, Borel Rinkes IH, Mali WP, et al. Breast MRI in nonpalpable breast lesions: a randomized trial with diagnostic and therapeutic outcome - MONET - study. Trials 2007; 8: 40.
36. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008; 26: 3248-58.
37. Mann RM, Loo CE, Wobbes T, et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 2010; 119: 415-22.